BUSINESS ACQUISITIONS (Tables)

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Schedule of Purchase Price Allocation

The following tables summarize the total consideration and the preliminary amounts of assets acquired and liabilities assumed for Solstas and Summit Health described above:

	Solstas		Summit Health
Cash	$	572	$	125
Estimated fair value of contingent consideration	—		22
Transaction related costs due to sellers	—		5
Total consideration	$	572	$	152

	Solstas			Summit Health
Allocation of purchase price:	Fair Value		Weighted Average Useful Life (in years)	Fair Value		Weighted Average Useful Life (in years)
Cash and cash equivalents	$	9		$	1
Accounts receivable, net	48			9
Current deferred income taxes	7			—
Other current assets	12			16
Property, plant and equipment, net	49			6
Goodwill	270			92
Intangible assets:
Customer relationships	203		20	33		15
Tradename	7		2	2		1
Software	—			3		4
Total intangible assets	210			38
Non-current deferred income taxes	42			—
Total assets acquired	647			162
Current liabilities	63			10
Non-current deferred income taxes	4			—
Other non-current liabilities	8			—
Total liabilities assumed	75			10
Net assets acquired	$	572		$	152

Schedule of Pro Forma Information

	2014		2013
	(unaudited)
Pro forma net revenues	$	7,520	$	7,622
Pro forma income from continuing operations	$	585	$	855
Earnings per share attributable to Quest Diagnostics’ common stockholders - basic:
Pro forma income from continuing operations	$	3.79	$	5.40
Earnings per share attributable to Quest Diagnostics’ common stockholders - diluted:
Pro forma income from continuing operations	$	3.77	$	5.36